leadf
logo-loader
viewTodos Medical Ltd.
(
OTCQB:TOMDF
)

Todos Medical completes validation of COVID-19 and respiratory panel tests

Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the Quidel (NASDAQ:QDEL) (NASDAQ:QDEL) Lyra Influenza A & B and the Lyra RSV & hMPV PCR kits into production.

Commissiong says kits will be produced alongside COVID PCR tests currently being run (Provista Respiratory Panel) and expects this new respiratory panel to be launched in September 2021.

Quick facts: Todos Medical Ltd.

Follow
OTCQB:TOMDF

Price: 0.041 USD

Market Cap: $24.7 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Todos Medical accepting cryptocurrency to purchase Tollovid and Tollovid...

Todos Medical Ltd CEO Gerald Commissiong tells Proactive New York it biotechnology group is now accepting Bitcoin, Ethereum, Dogecoin, Bitcoin Cash, and Litecoin as payment for its proprietary 3CL protease inhibitor wellness products Tollovid and Tollovid Daily. Commissiong says the group has...

1 week, 1 day ago

2 min read